InternetIntelligenz 2.0

kostenlos Pressemitteilungen einstellen | veröffentlichen | verteilen

Pressemitteilungen

 

3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years

ID: 1771515

The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 570.4 Million in 2016 growing at a CAGR of 20.3%


(IINews) - A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions.

Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the 3d cell culture market.

The Global 3d cell culture market to offer business growth of $1720.3 million in coming years.

To Gain Crucial Insights Into the Market | Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

Developing Alternative to Animal Testing:

Animal models are widely used in cell biology research for studying human-specific diseases. However, this carries several disadvantages—the possibility of harm to animals, difficulties in ensuring result accuracy due to differences in species, disease mechanisms, and drug responses. To overcome these issues, various institutes are involved in developing alternative methods for drug development.

As 3D cell cultures can serve as an economical alternative to animal models, the current focus on lessening animal use in research is expected to support the growth of the 3D cell culture market.

Regenerative Medicine, an Alternative to Organ Transplantation:

Regenerative medicine a branch of translational research that involves the regeneration of human cells, tissues, and organs is gaining increasing importance. 3D cell culture can be employed to create a 3D cellular environment that mimics the physiological conditions of major organ systems; innovative techniques, such as 3D bioprinting and microfluidics can also be used for tissue and organ generation. The focus on regenerative medicine and 3D cell culture in this application is expected to grow significantly in the future, which will showcase strong growth opportunities for stakeholders in 3d cell culture market.





Cancer and Stem Cell Research:

The cancer and stem cell research segment is estimated to account for the largest market share in 3d cell culture market. Growth of this application segment is attributed to increasing incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations.

Pharmaceuticals and Biotechnology Industries:

Pharmaceutical and biotechnology companies are expected to form the largest end-user segment. The presence of a large number of pharmaceutical and biotechnology companies, increasing R&D spending in these companies, and growing focus on alternative testing models instead of animal techniques are the key drivers for this end-user segment.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847

North America the Land of Opportunities in 3D Cell Culture Market:

The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as increase in incidence of cancer, presence of well-established pharmaceutical and biotechnology industry, and availability of technologically advanced products.

The 3D cell culture market is highly competitive with the presence of various players. Some of the major players operating in the market are Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas (Netherlands), Emulate (US), Nano3D Biosciences (US), and QGel (Switzerland).


Themen in diesem Fachartikel:


Unternehmensinformation / Kurzprofil:

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies'' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets''s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.



Leseranfragen:



PresseKontakt / Agentur:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com



drucken  als PDF  an Freund senden  Seno Medical und Mallinckrodt gibt bekannt, dass UVADEX® (Methoxsalen) in Australien für die Verwendung mit dem THERAKOS® CELLEX® Photopheresesystem für die Behandlung der chronischen Graft-versus-Host-Reaktion (cGvHR) und Hautmanifestationen von kutanen T-Zell Lympho...
Bereitgestellt von Benutzer: dheerajshaha67
Datum: 18.11.2019 - 10:20 Uhr
Sprache: Deutsch
News-ID 1771515
Anzahl Zeichen: 0

Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:

Northbrook


Telefon: 18886006441

Kategorie:

Biotechnologie


Anmerkungen:


Dieser Fachartikel wurde bisher 159 mal aufgerufen.


Der Fachartikel mit dem Titel:
"3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years
"
steht unter der journalistisch-redaktionellen Verantwortung von

MnM (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von MnM



 

Wer ist Online

Alle Mitglieder: 50.210
Registriert Heute: 0
Registriert Gestern: 0
Mitglied(er) online: 0
Gäste Online: 109


Bitte registrieren Sie sich hier. Als angemeldeter Benutzer nutzen Sie den vollen Funktionsumfang dieser Seite.